@ericotop.bsky.social
📚 Aerobic Exercise Affected Lymphocyte Apoptosis by Modulating ROS Release and NLRP3 Inflammasome Activation.
🔗 https://doi.org/10.1007/s10517-025-06398-8
🔗 https://doi.org/10.1007/s10517-025-06398-8
April 30, 2025 at 12:51 AM
📚 Aerobic Exercise Affected Lymphocyte Apoptosis by Modulating ROS Release and NLRP3 Inflammasome Activation.
🔗 https://doi.org/10.1007/s10517-025-06398-8
🔗 https://doi.org/10.1007/s10517-025-06398-8
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 4:29 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
https://hal.science/5032434
https://hal.science/5032434
April 29, 2025 at 4:21 AM
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
https://hal.science/5032434
https://hal.science/5032434
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 3:07 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
FLASH radiotherapy spares lymphocytes in tumor-draining lymph nodes and increases infiltration of immune cells in tumors.
https://doi.org/10.1101/2025.04.07.647544
https://doi.org/10.1101/2025.04.07.647544
April 29, 2025 at 1:34 AM
FLASH radiotherapy spares lymphocytes in tumor-draining lymph nodes and increases infiltration of immune cells in tumors.
https://doi.org/10.1101/2025.04.07.647544
https://doi.org/10.1101/2025.04.07.647544
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 1:26 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 1:21 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 1:17 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 1:16 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 12:52 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
April 29, 2025 at 12:52 AM
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy.
https://doi.org/10.3389/fimmu.2025.1562797
https://doi.org/10.3389/fimmu.2025.1562797
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
https://doi.org/10.1002/ctm2.70163
https://doi.org/10.1002/ctm2.70163
April 27, 2025 at 2:11 PM
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
https://doi.org/10.1002/ctm2.70163
https://doi.org/10.1002/ctm2.70163
Patient-Reported Burden of Indolent Systemic Mastocytosis in a Managed Care Organization-Correspondence.
https://doi.org/10.1111/1756-185X.70241
https://doi.org/10.1111/1756-185X.70241
April 27, 2025 at 1:49 PM
Patient-Reported Burden of Indolent Systemic Mastocytosis in a Managed Care Organization-Correspondence.
https://doi.org/10.1111/1756-185X.70241
https://doi.org/10.1111/1756-185X.70241
Mastocytosis.
https://doi.org/10.1038/s41572-025-00611-8
https://doi.org/10.1038/s41572-025-00611-8
April 27, 2025 at 1:48 PM
Mastocytosis.
https://doi.org/10.1038/s41572-025-00611-8
https://doi.org/10.1038/s41572-025-00611-8
Mastocytosis.
https://doi.org/10.1038/s41572-025-00619-0
https://doi.org/10.1038/s41572-025-00619-0
April 27, 2025 at 5:47 AM
Mastocytosis.
https://doi.org/10.1038/s41572-025-00619-0
https://doi.org/10.1038/s41572-025-00619-0
Mastocytosis.
https://doi.org/10.1038/s41572-025-00619-0
https://doi.org/10.1038/s41572-025-00619-0
April 27, 2025 at 5:47 AM
Mastocytosis.
https://doi.org/10.1038/s41572-025-00619-0
https://doi.org/10.1038/s41572-025-00619-0
Systemic mastocytosis: Not the average case of back pain.
https://doi.org/10.1097/01.JAA.0000000000000202
https://doi.org/10.1097/01.JAA.0000000000000202
April 27, 2025 at 5:37 AM
Systemic mastocytosis: Not the average case of back pain.
https://doi.org/10.1097/01.JAA.0000000000000202
https://doi.org/10.1097/01.JAA.0000000000000202
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
https://doi.org/10.1002/ctm2.70163
https://doi.org/10.1002/ctm2.70163
April 27, 2025 at 5:37 AM
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
https://doi.org/10.1002/ctm2.70163
https://doi.org/10.1002/ctm2.70163
Claim Denials for Cancer-Related Next-Generation Sequencing in Medicare.
https://doi.org/10.1001/jamanetworkopen.2025.5785
https://doi.org/10.1001/jamanetworkopen.2025.5785
April 25, 2025 at 12:25 AM
Claim Denials for Cancer-Related Next-Generation Sequencing in Medicare.
https://doi.org/10.1001/jamanetworkopen.2025.5785
https://doi.org/10.1001/jamanetworkopen.2025.5785
Identification of the Novel HLA-B*38:125 Allele by Next-Generation Sequencing.
https://doi.org/10.1111/tan.70192
https://doi.org/10.1111/tan.70192
April 24, 2025 at 10:02 PM
Identification of the Novel HLA-B*38:125 Allele by Next-Generation Sequencing.
https://doi.org/10.1111/tan.70192
https://doi.org/10.1111/tan.70192
Biochemical assays for AID/APOBECs and the identification of AID/APOBEC inhibitors.
https://doi.org/10.1016/bs.mie.2024.12.001
https://doi.org/10.1016/bs.mie.2024.12.001
April 24, 2025 at 8:15 PM
Biochemical assays for AID/APOBECs and the identification of AID/APOBEC inhibitors.
https://doi.org/10.1016/bs.mie.2024.12.001
https://doi.org/10.1016/bs.mie.2024.12.001
Biological diagnosis of hereditary alpha-tryptasemia
https://hal.science/5012755
https://hal.science/5012755
April 24, 2025 at 4:54 AM
Biological diagnosis of hereditary alpha-tryptasemia
https://hal.science/5012755
https://hal.science/5012755
Synbiotics of encapsulated Limosilactobacillus fermentum K73 promotes in vitro favorable gut microbiota shifts and enhances short-chain fatty acid production in fecal samples of children with autism spectrum disorder.
https://doi.org/10.1016/j.foodres.2025.116227
https://doi.org/10.1016/j.foodres.2025.116227
April 22, 2025 at 3:17 AM
Synbiotics of encapsulated Limosilactobacillus fermentum K73 promotes in vitro favorable gut microbiota shifts and enhances short-chain fatty acid production in fecal samples of children with autism spectrum disorder.
https://doi.org/10.1016/j.foodres.2025.116227
https://doi.org/10.1016/j.foodres.2025.116227
In vitro colonic fermentation of clean label ham formulations: Gut microbiota modulation and metabolite production.
https://doi.org/10.1016/j.foodres.2025.116287
https://doi.org/10.1016/j.foodres.2025.116287
April 22, 2025 at 1:02 AM
In vitro colonic fermentation of clean label ham formulations: Gut microbiota modulation and metabolite production.
https://doi.org/10.1016/j.foodres.2025.116287
https://doi.org/10.1016/j.foodres.2025.116287
Identification of the Novel HLA-DQA1*05:01:21 Allele by Next-Generation Sequencing.
https://doi.org/10.1111/tan.70191
https://doi.org/10.1111/tan.70191
April 21, 2025 at 6:24 AM
Identification of the Novel HLA-DQA1*05:01:21 Allele by Next-Generation Sequencing.
https://doi.org/10.1111/tan.70191
https://doi.org/10.1111/tan.70191